IP‐10 predicts viral response and therapeutic outcome in difficult‐to‐treat patients with HCV genotype 1 infection
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP‐10 levels prior
to treatment with pegylated interferon‐α‐2a and ribavirin. Significantly lower IP‐10 levels …
to treatment with pegylated interferon‐α‐2a and ribavirin. Significantly lower IP‐10 levels …
[PDF][PDF] IP-10 Predicts Viral Response and Therapeutic Outcome in Difficult-to-Treat Patients With HCV Genotype 1 Infection
M Lagging, AI Romero, J Westin, G Norkrans… - …, 2006 - academia.edu
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon--2a and ribavirin. Significantly lower IP-10 levels were …
to treatment with pegylated interferon--2a and ribavirin. Significantly lower IP-10 levels were …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M Lagging, AI Romero, J Westin, G Norkrans… - HEPATOLOGY, 2006 - air.unipr.it
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M Lagging, S Schalm, B Haagmans, C Ferrari… - Hepatology, 2006 - repub.eur.nl
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
[引用][C] IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M LAGGING, AI ROMERO… - Hepatology …, 2006 - pascal-francis.inist.fr
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV
genotype 1 infection CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
genotype 1 infection CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
M Lagging, AI Romero, J Westin, G Norkrans… - 2006 - cabidigitallibrary.org
Plasma from 173 patients with HCV genotype 1 infection was analysed for IP-10 levels prior
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
M Lagging, AI Romero, J Westin… - Hepatology …, 2006 - europepmc.org
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon-alpha-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-alpha-2a and ribavirin. Significantly lower IP-10 levels …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M Lagging, AI Romero, J Westin, G Norkrans… - Hepatology, 2006 - journals.lww.com
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels …
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M Lagging, AI Romero, J Westin, G Norkrans… - 2006 - pubmed.ncbi.nlm.nih.gov
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior
to treatment with pegylated interferon-alpha-2a and ribavirin. Significantly lower IP-10 levels …
to treatment with pegylated interferon-alpha-2a and ribavirin. Significantly lower IP-10 levels …
[引用][C] IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
M Lagging, AI Romero, J Westin, G Norkrans… - Hepatology, 2006 - cir.nii.ac.jp
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV
genotype 1 infection | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
genotype 1 infection | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …